The Nanomedicine Translation Advisory Board is a service that has been designed as the prime initiative to help the European nanomedicine community not to get lost in translation.
Apply to the TAB
About the nanomedTAB
The Nanomedicine Translation Advisory Board provides you unique, free of charge access to high-level experts, who will advise and guide you to accelerate your project to the market. The TAB wants to help you to make the right strategic choices at the right time, reducing risks and maximizing the chances of success.
- Stage-gate service that offers free one-to-one advice sessions to the European nanomedicine community at any stage of their nanobiomedical endeavours. Duration and depth of the advisory service depends on the merit of each project to qualify for the different stages of the service.
- The content is driven by the needs each project brings, and tailored to the beneficiaries’ ultimate concerns and expectations. It may include topics such as R&D; process development, optimisation and scale-up; safety and quality control; clinical investigation; regulatory and reimbursement issues; intellectual property rights and licensing; business strategy, business modelling and development, funding strategies; networking, collaboration, commercialisation.
- Advice aims at responding to projects’ needs including access to clinical centres for first studies in patients, financial resources from investors and/or large companies to accelerate critical steps to market.
- Most promising projects will be eligible for further high value services such as showcase opportunities to clinical trial centres, investors and large companies. Special coaching sessions may be organised prior to showcasing events.
- The nature of the advice and recommendations to be provided is not binding, meaning that beneficiaries may or not follow advice and recommendations at their own discretion.
What the community is saying about us
Our experience with nanomedTAB has been invaluable: a game changer, turning the page for the next part of the journey towards both clinical and commercial success.
The depth of interest plus knowledge of our TAB Experts provided immediate interactive engagement that followed throughout the presentation and the subsequent constructive analysis. The Expert critique has been taken on board and is guiding our current activities. TAB's commercial insight has brought focus on need to refine, and define further, the company. Here alliance with TAB plus link to EU-NCL increases our commercial credibility including endorsement of our aims. We are most grateful to the TAB and especially to our TAB Experts and look forward to further interactions.
The Basel meeting with the TAB was such a special opportunity to get valuable advice from real life business professionals. Both advisors provided pratical guidance on ways to pitch the technology, market positioning and avoidance of risks. It was an enlightening experience in terms of how to approach regulatory agencies and what is required in advance. We do really appreciate the opportunity and would be pleased to proceed to the next stage, if selected.
We had the opportunity to present our Project in the Stage I TAB-in session in a Skype meeting. The advice provided by all the experts helped us to focus our efforts more specifically. They highlighted the importance of defining the target market in order to have more figures to support the business case for the product. We understood also the need for having key opinion leaders’ support to convince possible future investors. Thus, we think that with the control from the experts our project will gain in maturity and will end in a successful technological product.
The experience in Basel, during the TAB in session was very useful. We had the opportunity to discuss with the experts our project and get from them feedback, advices and help, to inspire our team for improving our project. We are really proud for getting this experience. The recommendations from the experts will help us to focus many aspects regarding to our project. It was a pleasure having this experience in Basel. Thank you very much!
To have the opportunity of presenting our project in the Stage I TAB-in session was exceptional and very stimulating. The advice we could get from high level experts in Pharma Development and Business was for us of extremely high value. We are, indeed, moving ahead with our idea in a more effective manner and are looking forward an active communication with our advisers. We believe this initiative is an essential instrument for helping academics and SMEs with a clear translational vocation.
My presence at the TAB-IN sessions was a great opportunity to discuss strategies and ideas with experts in the nanomedicine translation. As such, it is my strong belief that these sessions are very important to fill in the gap between academia and the industry. The experts were able to tackle the major issues regarding our project, identifying its major strengths and weaknesses, and the informal nature of the meeting allowed a fruitful discussion of strategies and ideas. The experts’ feedback helped us establish an order of priority for the upcoming tasks, thus setting us a guide to successfully develop our project. The local support from the organizing committee and the lovely Dublin sights also contributed to an overall positive experience.
The participation on the TAB-In Sessions was very profitable. The consultants have shown me the potential pitfalls and the requisites my project has to meet in order to succeed. The experts also provided some interesting insight and ideas about how to attract investment and help important stakeholders to recognize our product and our technology as innovative and promising.
During the Stage I TAB-In session held in Dublin I had a chance to meet two enthusiastic, friendly and highly competent TAB experts. They appeared to be genuinely interested in my project story and rendered the 2-hour discussion pleasant and fully stimulating. During the discussion they posed highly relevant questions and carefully evaluated all answers. They specifically addressed some business opportunity and fund raising aspects and at the end of the meeting they gave factive suggestions regarding product exploitation and commercialization which will surely help us in further project development.
Our experience in Dublin during the first TAB-in session, has been without doubt very useful, as well as an experience that usually does not exist in the most cases of on-going academic scientific projects and of high value. Currently, the LIPOCELL project is industrially driven, as it is directly funded by BIOPRAXIS company, as well as by CIBER-BBN network . Nevertheless, there are some business related issues, as well as some clinical aspects, that were not clear yet how to address them properly at the moment of the meeting with the TAB committee. The TAB-in session board highlighted them after the presentation of the project and focused our attention on these critical issues. It is important and it is totally necessary that we keep in mind them during the progression of the project in the near future, if we want to succeed and arrive to the market in the best conditions for the developed nanomedicine. Finally, we are currently working on these highlighted issues and we will be happy to get more expert advice from the TAB board if they consider it of interest.
As a PhD student, it was a big challenge having the opportunity of presenting my idea at the TAB-In sessions. I have received very direct, precise and valuable feedback which helped me to better direct my work. The TAB-In session powered ideas into real projects and I couldn't be more proud of having this experience!
The TAB offered an invaluable opportunity to pitch the technology forward to a panel of experts in the field with varying and complementary expertise. Their insight and two-way discussion has been invaluable in developing a pathway for clinical development of our molecule, SAN101!
Adjuvatis is a startup recently founded which aims at developing fully metabolizable adjuvants and biodegradable, safe-by-design delivery systems. A developing project was submitted to the Nanomedicine Translation Advisory Board and selected for evaluation on October 2015. I was invited to present the project in Dublin a few days later. I was warmly welcomed by the group involved in ENATRANS support action. My project was presented to two experts in the field of bioresorbable materials, highly experienced in conducting business. This around 2 hours exchange was conducted in an open, curious and very encouraging mind! I received extremely relevant comments and advices. To create Adjuvatis, founder and I have benefit from two years of support which were very informative, but two hours of TAB experience have absolutely completed this initial training. My project has not passed the initial advisory stage, but for sure I’ll try my luck again!
The Dublin TAB-in session was very useful to better structure the next steps we should take in the project!
Fourth cut-off date of the TAB
The cut-off date for the 4th TAB-in Sessions, in London, UK, has been anounced. Submit your projects untill the 27th of February and be the next project to join more ...
Fourth cut-off date of the TAB
The cut-off date for the 4th TAB-in Sessions, in London, UK, has been anounced. Submit your projects untill the 27th of February and be the next project to join more than 40 projects already being supported by the TAB in the road to Nanomedicine Translation.
TAB-In Sessions in London
Projects selected in the 4th cut-off will be invited to join 2-hours individual sessions with experts in London, in parallel to the European Nanomedicine Meeting 2017. The TAB-In Sessions are the ...
TAB-In Sessions in London
Projects selected in the 4th cut-off will be invited to join 2-hours individual sessions with experts in London, in parallel to the European Nanomedicine Meeting 2017. The TAB-In Sessions are the entry point to the support service offered by the TAB.